Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
1 other identifier
observational
130
0 countries
N/A
Brief Summary
Magnetic resonance imaging (MRI) is the diagnostic cornerstone for precisely identifying acute ischaemic strokes and locating vascular occlusions. It was observed that a post-contrast three-dimensional turbo-spin-echo T1weighted sequence showed striking post-contrast vascular hyperintensities (PCVH) in ischaemic territories. The aim is to evaluate the prevalence and the meaning of this finding. This study included 130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset from September 2014 through September 2016. Two neuroradiologists blinded to clinical data analysed the first MRI assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 26, 2019
CompletedFirst Posted
Study publicly available on registry
June 3, 2019
CompletedJune 3, 2019
May 1, 2019
2 years
May 26, 2019
May 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
overal survival
from the AR-PML diagnosis date to that of death or censored on 31 December 2015
7 years
Interventions
MR images were reviewed by one junior radiologist and one senior neuroradiologist, both blinded to clinical, therapeutic and follow-up data.
Eligibility Criteria
130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset.
You may qualify if:
- Patients aged 18 and older at onset of an acute ischaemic stroke
- Availability of at least one pre-therapeutic MRI performed in our centre within 12 h of stroke onset, including a post-contrast 3D TSE T1-weighted sequence.
You may not qualify if:
- Patients with posterior fossa strokes
- Patients with known intracranial vasculitis or MoyaMoya disease
- Presence of severe MR imaging artefacts preventing correct interpretation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2019
First Posted
June 3, 2019
Study Start
September 1, 2014
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
June 3, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share